Immunotherapy Given Presurgically Showed Positive Results in EarlyStage Lung Cancer

Immunotherapy Given Presurgically Showed Positive Results in Early-Stage Lung Cancer

For patients with operable non-small cell lung cancer, pre-surgical neoadjuvant treatment with an immune checkpoint inhibitor was well tolerated and, in many cases, caused significant tumor cell death.

More From BioPortfolio on "Immunotherapy Given Presurgically Showed Positive Results in Early-Stage Lung Cancer"